Capstone Therapeutics to Present at Two Upcoming Conferences and to Host Conference Call Discussing Third Quarter 2008 Operating Results
October 14, 2008 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Oct. 14, 2008 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) is scheduled to make a presentation at the Seventh Annual BIO Investor Forum at 8:00am Wednesday, October 29, 2008...
OrthoLogic Corp. Announces New Company Name: Capstone Therapeutics
September 30, 2008 16:30 ET
|
Capstone Therapeutics
TEMPE, Ariz., Sept. 30, 2008 (GLOBE NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) announced today that effective October 1, 2008, the Company will be known and doing business as Capstone Therapeutics....
AZX100 Pre-Clinical Results Show Reduction of Fibrosis and Scarring; Human Clinical Safety Trials Continuing
September 12, 2008 08:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Sept. 12, 2008 (GLOBE NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) announced today the publication of positive results from pre-clinical studies of AZX100 in the management of excessive...
Chrysalin (Rusalatide Acetate, TP508) Pre-Clinical Results Show Significant Beneficial Effect in Chronic Heart Disease
September 03, 2008 09:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Sept. 3, 2008 (GLOBE NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) announced today the publication of positive results from a pre-clinical study of Chrysalin(r) (rusalatide acetate or...
OrthoLogic Announces Completion of Dosing for Second AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
August 14, 2008 20:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 14, 2008 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) announced today the completion of dosing for its second AZX100 Phase 1 human clinical trial in dermal/hypertrophic...
OrthoLogic to Present At Fourth Annual Noble Financial Equity Conference August 19, 2008
August 12, 2008 19:30 ET
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 12, 2008 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) is scheduled to make a presentation at the Fourth Annual Noble Financial Equity Conference, Loews Lake Las Vegas Resort,...
OrthoLogic Corp. Receives Nasdaq Notice Letter
August 11, 2008 17:17 ET
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 11, 2008 (PRIME NEWSWIRE) -- OrthoLogic Corp. ("the Company") received a letter from The Nasdaq Stock Market, dated August 8, 2008, notifying it that for the 30 consecutive business...
OrthoLogic Announces Chrysalin (TP508) Demonstrates Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
August 07, 2008 09:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 7, 2008 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) announced today that Chrysalin(r) (rusalatide acetate or TP508), administered following the onset of ischemia, has shown a...
OrthoLogic Announces Second Quarter 2008 Financial Results
August 07, 2008 09:00 ET
|
Capstone Therapeutics
TEMPE, Ariz., Aug. 7, 2008 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) today announced financial results for the second quarter 2008.
OrthoLogic reported a net loss of $2.8 million, or $0.07...
OrthoLogic to Host Conference Call Discussing Second Quarter 2008 Operating Results
July 31, 2008 07:10 ET
|
Capstone Therapeutics
TEMPE, Ariz., July 31, 2008 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) announced today that it will release financial and operating results for the second quarter ending June 30, 2008, on...